Clairfield advises Cairdac on its equity raising from Merieux Equity Partners, Supernova Invest, Bpifrance and Turenne Capital (Sham)
Cairdac, a French medtech company that is developing a unique self‐sustainable dual‐chamber leadless pacemaker, raised EUR 17 million from Mérieux Equity Partners, Supernova Invest, Bpifrance, and Sham Innovation Santé (advised by Turenne).
Advisor to Cairdac
Debt & capital advisory
Countries involved :
Deal team :